- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Gene Therapies for Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Gene Therapies for Cancer Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Cancer Research Centers accounting for % of the Gene Therapies for Cancer Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Somatic Cell Gene Therapy (SCGT) segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Gene Therapies for Cancer Treatment include Takara Bio, Tocagen, VBL Therapeutics, Cold Genesys, and Genprex, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gene Therapies for Cancer Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Somatic Cell Gene Therapy (SCGT)
Germline Gene Therapy (GGT)
Market segment by Application, can be divided into
Cancer Research Centers
Diagnostic Laboratories
Cancer Hospitals
Others
Market segment by players, this report covers
Takara Bio
Tocagen
VBL Therapeutics
Cold Genesys
Genprex
Momotaro-Gene
MultiVir
SynerGene Therapeutics
Ziopharm Oncology
Anchiano Therapeutics
Celgene
Celsion
Bluebird Bio
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Gene Therapies for Cancer Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Gene Therapies for Cancer Treatment, with revenue, gross margin and global market share of Gene Therapies for Cancer Treatment from 2019 to 2022.
Chapter 3, the Gene Therapies for Cancer Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Gene Therapies for Cancer Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Gene Therapies for Cancer Treatment research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Gene Therapies for Cancer Treatment
1.2 Classification of Gene Therapies for Cancer Treatment by Type
1.2.1 Overview: Global Gene Therapies for Cancer Treatment Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Type in 2021
1.2.3 Somatic Cell Gene Therapy (SCGT)
1.2.4 Germline Gene Therapy (GGT)
1.3 Global Gene Therapies for Cancer Treatment Market by Application
1.3.1 Overview: Global Gene Therapies for Cancer Treatment Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cancer Research Centers
1.3.3 Diagnostic Laboratories
1.3.4 Cancer Hospitals
1.3.5 Others
1.4 Global Gene Therapies for Cancer Treatment Market Size & Forecast
1.5 Global Gene Therapies for Cancer Treatment Market Size and Forecast by Region
1.5.1 Global Gene Therapies for Cancer Treatment Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Gene Therapies for Cancer Treatment Market Size by Region, (2017-2022)
1.5.3 North America Gene Therapies for Cancer Treatment Market Size and Prospect (2017-2028)
1.5.4 Europe Gene Therapies for Cancer Treatment Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Gene Therapies for Cancer Treatment Market Size and Prospect (2017-2028)
1.5.6 South America Gene Therapies for Cancer Treatment Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Gene Therapies for Cancer Treatment Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gene Therapies for Cancer Treatment Market Drivers
1.6.2 Gene Therapies for Cancer Treatment Market Restraints
1.6.3 Gene Therapies for Cancer Treatment Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Takara Bio
2.1.1 Takara Bio Details
2.1.2 Takara Bio Major Business
2.1.3 Takara Bio Gene Therapies for Cancer Treatment Product and Solutions
2.1.4 Takara Bio Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Takara Bio Recent Developments and Future Plans
2.2 Tocagen
2.2.1 Tocagen Details
2.2.2 Tocagen Major Business
2.2.3 Tocagen Gene Therapies for Cancer Treatment Product and Solutions
2.2.4 Tocagen Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Tocagen Recent Developments and Future Plans
2.3 VBL Therapeutics
2.3.1 VBL Therapeutics Details
2.3.2 VBL Therapeutics Major Business
2.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Product and Solutions
2.3.4 VBL Therapeutics Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 VBL Therapeutics Recent Developments and Future Plans
2.4 Cold Genesys
2.4.1 Cold Genesys Details
2.4.2 Cold Genesys Major Business
2.4.3 Cold Genesys Gene Therapies for Cancer Treatment Product and Solutions
2.4.4 Cold Genesys Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Cold Genesys Recent Developments and Future Plans
2.5 Genprex
2.5.1 Genprex Details
2.5.2 Genprex Major Business
2.5.3 Genprex Gene Therapies for Cancer Treatment Product and Solutions
2.5.4 Genprex Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Genprex Recent Developments and Future Plans
2.6 Momotaro-Gene
2.6.1 Momotaro-Gene Details
2.6.2 Momotaro-Gene Major Business
2.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Product and Solutions
2.6.4 Momotaro-Gene Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Momotaro-Gene Recent Developments and Future Plans
2.7 MultiVir
2.7.1 MultiVir Details
2.7.2 MultiVir Major Business
2.7.3 MultiVir Gene Therapies for Cancer Treatment Product and Solutions
2.7.4 MultiVir Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 MultiVir Recent Developments and Future Plans
2.8 SynerGene Therapeutics
2.8.1 SynerGene Therapeutics Details
2.8.2 SynerGene Therapeutics Major Business
2.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Product and Solutions
2.8.4 SynerGene Therapeutics Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 SynerGene Therapeutics Recent Developments and Future Plans
2.9 Ziopharm Oncology
2.9.1 Ziopharm Oncology Details
2.9.2 Ziopharm Oncology Major Business
2.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Product and Solutions
2.9.4 Ziopharm Oncology Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Ziopharm Oncology Recent Developments and Future Plans
2.10 Anchiano Therapeutics
2.10.1 Anchiano Therapeutics Details
2.10.2 Anchiano Therapeutics Major Business
2.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Product and Solutions
2.10.4 Anchiano Therapeutics Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Anchiano Therapeutics Recent Developments and Future Plans
2.11 Celgene
2.11.1 Celgene Details
2.11.2 Celgene Major Business
2.11.3 Celgene Gene Therapies for Cancer Treatment Product and Solutions
2.11.4 Celgene Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Celgene Recent Developments and Future Plans
2.12 Celsion
2.12.1 Celsion Details
2.12.2 Celsion Major Business
2.12.3 Celsion Gene Therapies for Cancer Treatment Product and Solutions
2.12.4 Celsion Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Celsion Recent Developments and Future Plans
2.13 Bluebird Bio
2.13.1 Bluebird Bio Details
2.13.2 Bluebird Bio Major Business
2.13.3 Bluebird Bio Gene Therapies for Cancer Treatment Product and Solutions
2.13.4 Bluebird Bio Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Bluebird Bio Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Gene Therapies for Cancer Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Gene Therapies for Cancer Treatment Players Market Share in 2021
3.2.2 Top 10 Gene Therapies for Cancer Treatment Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Gene Therapies for Cancer Treatment Players Head Office, Products and Services Provided
3.4 Gene Therapies for Cancer Treatment Mergers & Acquisitions
3.5 Gene Therapies for Cancer Treatment New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Gene Therapies for Cancer Treatment Revenue and Market Share by Type (2017-2022)
4.2 Global Gene Therapies for Cancer Treatment Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2017-2022)
5.2 Global Gene Therapies for Cancer Treatment Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Gene Therapies for Cancer Treatment Revenue by Type (2017-2028)
6.2 North America Gene Therapies for Cancer Treatment Revenue by Application (2017-2028)
6.3 North America Gene Therapies for Cancer Treatment Market Size by Country
6.3.1 North America Gene Therapies for Cancer Treatment Revenue by Country (2017-2028)
6.3.2 United States Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
6.3.3 Canada Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
6.3.4 Mexico Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Gene Therapies for Cancer Treatment Revenue by Type (2017-2028)
7.2 Europe Gene Therapies for Cancer Treatment Revenue by Application (2017-2028)
7.3 Europe Gene Therapies for Cancer Treatment Market Size by Country
7.3.1 Europe Gene Therapies for Cancer Treatment Revenue by Country (2017-2028)
7.3.2 Germany Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
7.3.3 France Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
7.3.5 Russia Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
7.3.6 Italy Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Gene Therapies for Cancer Treatment Revenue by Type (2017-2028)
8.2 Asia-Pacific Gene Therapies for Cancer Treatment Revenue by Application (2017-2028)
8.3 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region
8.3.1 Asia-Pacific Gene Therapies for Cancer Treatment Revenue by Region (2017-2028)
8.3.2 China Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
8.3.3 Japan Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
8.3.4 South Korea Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
8.3.5 India Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
8.3.7 Australia Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Gene Therapies for Cancer Treatment Revenue by Type (2017-2028)
9.2 South America Gene Therapies for Cancer Treatment Revenue by Application (2017-2028)
9.3 South America Gene Therapies for Cancer Treatment Market Size by Country
9.3.1 South America Gene Therapies for Cancer Treatment Revenue by Country (2017-2028)
9.3.2 Brazil Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
9.3.3 Argentina Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Gene Therapies for Cancer Treatment Revenue by Type (2017-2028)
10.2 Middle East & Africa Gene Therapies for Cancer Treatment Revenue by Application (2017-2028)
10.3 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country
10.3.1 Middle East & Africa Gene Therapies for Cancer Treatment Revenue by Country (2017-2028)
10.3.2 Turkey Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
10.3.4 UAE Gene Therapies for Cancer Treatment Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Gene Therapies for Cancer Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Gene Therapies for Cancer Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Gene Therapies for Cancer Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Gene Therapies for Cancer Treatment Revenue (USD Million) by Region (2017-2022)
Table 5. Global Gene Therapies for Cancer Treatment Revenue Market Share by Region (2023-2028)
Table 6. Takara Bio Corporate Information, Head Office, and Major Competitors
Table 7. Takara Bio Major Business
Table 8. Takara Bio Gene Therapies for Cancer Treatment Product and Solutions
Table 9. Takara Bio Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Tocagen Corporate Information, Head Office, and Major Competitors
Table 11. Tocagen Major Business
Table 12. Tocagen Gene Therapies for Cancer Treatment Product and Solutions
Table 13. Tocagen Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. VBL Therapeutics Corporate Information, Head Office, and Major Competitors
Table 15. VBL Therapeutics Major Business
Table 16. VBL Therapeutics Gene Therapies for Cancer Treatment Product and Solutions
Table 17. VBL Therapeutics Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Cold Genesys Corporate Information, Head Office, and Major Competitors
Table 19. Cold Genesys Major Business
Table 20. Cold Genesys Gene Therapies for Cancer Treatment Product and Solutions
Table 21. Cold Genesys Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Genprex Corporate Information, Head Office, and Major Competitors
Table 23. Genprex Major Business
Table 24. Genprex Gene Therapies for Cancer Treatment Product and Solutions
Table 25. Genprex Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Momotaro-Gene Corporate Information, Head Office, and Major Competitors
Table 27. Momotaro-Gene Major Business
Table 28. Momotaro-Gene Gene Therapies for Cancer Treatment Product and Solutions
Table 29. Momotaro-Gene Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. MultiVir Corporate Information, Head Office, and Major Competitors
Table 31. MultiVir Major Business
Table 32. MultiVir Gene Therapies for Cancer Treatment Product and Solutions
Table 33. MultiVir Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. SynerGene Therapeutics Corporate Information, Head Office, and Major Competitors
Table 35. SynerGene Therapeutics Major Business
Table 36. SynerGene Therapeutics Gene Therapies for Cancer Treatment Product and Solutions
Table 37. SynerGene Therapeutics Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Ziopharm Oncology Corporate Information, Head Office, and Major Competitors
Table 39. Ziopharm Oncology Major Business
Table 40. Ziopharm Oncology Gene Therapies for Cancer Treatment Product and Solutions
Table 41. Ziopharm Oncology Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Anchiano Therapeutics Corporate Information, Head Office, and Major Competitors
Table 43. Anchiano Therapeutics Major Business
Table 44. Anchiano Therapeutics Gene Therapies for Cancer Treatment Product and Solutions
Table 45. Anchiano Therapeutics Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Celgene Corporate Information, Head Office, and Major Competitors
Table 47. Celgene Major Business
Table 48. Celgene Gene Therapies for Cancer Treatment Product and Solutions
Table 49. Celgene Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Celsion Corporate Information, Head Office, and Major Competitors
Table 51. Celsion Major Business
Table 52. Celsion Gene Therapies for Cancer Treatment Product and Solutions
Table 53. Celsion Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Bluebird Bio Corporate Information, Head Office, and Major Competitors
Table 55. Bluebird Bio Major Business
Table 56. Bluebird Bio Gene Therapies for Cancer Treatment Product and Solutions
Table 57. Bluebird Bio Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Gene Therapies for Cancer Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Gene Therapies for Cancer Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Gene Therapies for Cancer Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Gene Therapies for Cancer Treatment Players Head Office, Products and Services Provided
Table 62. Gene Therapies for Cancer Treatment Mergers & Acquisitions in the Past Five Years
Table 63. Gene Therapies for Cancer Treatment New Entrants and Expansion Plans
Table 64. Global Gene Therapies for Cancer Treatment Revenue (USD Million) by Type (2017-2022)
Table 65. Global Gene Therapies for Cancer Treatment Revenue Share by Type (2017-2022)
Table 66. Global Gene Therapies for Cancer Treatment Revenue Forecast by Type (2023-2028)
Table 67. Global Gene Therapies for Cancer Treatment Revenue by Application (2017-2022)
Table 68. Global Gene Therapies for Cancer Treatment Revenue Forecast by Application (2023-2028)
Table 69. North America Gene Therapies for Cancer Treatment Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Gene Therapies for Cancer Treatment Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Gene Therapies for Cancer Treatment Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Gene Therapies for Cancer Treatment Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Gene Therapies for Cancer Treatment Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Gene Therapies for Cancer Treatment Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Gene Therapies for Cancer Treatment Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Gene Therapies for Cancer Treatment Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Gene Therapies for Cancer Treatment Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Gene Therapies for Cancer Treatment Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Gene Therapies for Cancer Treatment Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Gene Therapies for Cancer Treatment Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Gene Therapies for Cancer Treatment Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Gene Therapies for Cancer Treatment Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Gene Therapies for Cancer Treatment Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Gene Therapies for Cancer Treatment Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Gene Therapies for Cancer Treatment Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Gene Therapies for Cancer Treatment Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Gene Therapies for Cancer Treatment Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Gene Therapies for Cancer Treatment Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Gene Therapies for Cancer Treatment Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Gene Therapies for Cancer Treatment Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Gene Therapies for Cancer Treatment Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Gene Therapies for Cancer Treatment Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Gene Therapies for Cancer Treatment Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Gene Therapies for Cancer Treatment Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Gene Therapies for Cancer Treatment Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Gene Therapies for Cancer Treatment Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Gene Therapies for Cancer Treatment Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Gene Therapies for Cancer Treatment Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Gene Therapies for Cancer Treatment Picture
Figure 2. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type in 2021
Figure 3. Somatic Cell Gene Therapy (SCGT)
Figure 4. Germline Gene Therapy (GGT)
Figure 5. Gene Therapies for Cancer Treatment Revenue Market Share by Application in 2021
Figure 6. Cancer Research Centers Picture
Figure 7. Diagnostic Laboratories Picture
Figure 8. Cancer Hospitals Picture
Figure 9. Others Picture
Figure 10. Global Gene Therapies for Cancer Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Gene Therapies for Cancer Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Gene Therapies for Cancer Treatment Revenue Market Share by Region (2017-2028)
Figure 13. Global Gene Therapies for Cancer Treatment Revenue Market Share by Region in 2021
Figure 14. North America Gene Therapies for Cancer Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Gene Therapies for Cancer Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Gene Therapies for Cancer Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Gene Therapies for Cancer Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Gene Therapies for Cancer Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Gene Therapies for Cancer Treatment Market Drivers
Figure 20. Gene Therapies for Cancer Treatment Market Restraints
Figure 21. Gene Therapies for Cancer Treatment Market Trends
Figure 22. Takara Bio Recent Developments and Future Plans
Figure 23. Tocagen Recent Developments and Future Plans
Figure 24. VBL Therapeutics Recent Developments and Future Plans
Figure 25. Cold Genesys Recent Developments and Future Plans
Figure 26. Genprex Recent Developments and Future Plans
Figure 27. Momotaro-Gene Recent Developments and Future Plans
Figure 28. MultiVir Recent Developments and Future Plans
Figure 29. SynerGene Therapeutics Recent Developments and Future Plans
Figure 30. Ziopharm Oncology Recent Developments and Future Plans
Figure 31. Anchiano Therapeutics Recent Developments and Future Plans
Figure 32. Celgene Recent Developments and Future Plans
Figure 33. Celsion Recent Developments and Future Plans
Figure 34. Bluebird Bio Recent Developments and Future Plans
Figure 35. Global Gene Therapies for Cancer Treatment Revenue Share by Players in 2021
Figure 36. Gene Therapies for Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players Gene Therapies for Cancer Treatment Revenue Market Share in 2021
Figure 38. Global Top 10 Players Gene Therapies for Cancer Treatment Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global Gene Therapies for Cancer Treatment Revenue Share by Type in 2021
Figure 41. Global Gene Therapies for Cancer Treatment Market Share Forecast by Type (2023-2028)
Figure 42. Global Gene Therapies for Cancer Treatment Revenue Share by Application in 2021
Figure 43. Global Gene Therapies for Cancer Treatment Market Share Forecast by Application (2023-2028)
Figure 44. North America Gene Therapies for Cancer Treatment Sales Market Share by Type (2017-2028)
Figure 45. North America Gene Therapies for Cancer Treatment Sales Market Share by Application (2017-2028)
Figure 46. North America Gene Therapies for Cancer Treatment Revenue Market Share by Country (2017-2028)
Figure 47. United States Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Gene Therapies for Cancer Treatment Sales Market Share by Type (2017-2028)
Figure 51. Europe Gene Therapies for Cancer Treatment Sales Market Share by Application (2017-2028)
Figure 52. Europe Gene Therapies for Cancer Treatment Revenue Market Share by Country (2017-2028)
Figure 53. Germany Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Gene Therapies for Cancer Treatment Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific Gene Therapies for Cancer Treatment Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Gene Therapies for Cancer Treatment Revenue Market Share by Region (2017-2028)
Figure 61. China Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Gene Therapies for Cancer Treatment Sales Market Share by Type (2017-2028)
Figure 68. South America Gene Therapies for Cancer Treatment Sales Market Share by Application (2017-2028)
Figure 69. South America Gene Therapies for Cancer Treatment Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa Gene Therapies for Cancer Treatment Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Gene Therapies for Cancer Treatment Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Gene Therapies for Cancer Treatment Revenue Market Share by Country (2017-2028)
Figure 75. Turkey Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE Gene Therapies for Cancer Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
